This site is intended for healthcare professionals only
LoginRegister
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon partners with Tabuk Pharma to commercialize GLP -1 products in Middle East region
Pfizer, TevaConduct Active Surveillance Study: CDSCO Panel Tells Pfizer on Abrocitinib tablets
Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCO5 formulations declared as spurious including Sun Pharma's Ursocol 300, Glenmark's Telma H
Dr ReddyMexican drug regulator imposes Rs 28 lakh penalty on Dr Reddy's Labs
Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI StatusCipla UK arm inks pact to purchase 6.9124 percent stake in Cipla Jiangsu Pharma
Piramal Pharma targets to be over USD 2 billion firm by FY30, says Chairperson Nandini PiramalPiramal Pharma targets to be over USD 2 billion firm by FY30, says Chairperson Nandini Piramal
Intas PharmaIntas Pharma, Henlius receive positive CHMP opinion for Hetronifly in European markets as first line...
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA completes audit at Jubilant HollisterStier 2 Washington facilities
Torsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngenes Proposal for BA/BE studyTorsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngene's Proposal for BA/BE study
Lillys Retatrutide Shows Strong Sugar, Weight Loss Gains in Late-Stage TrialEli Lilly Kisunla approved in Japan for early Symptomatic Alzheimer's disease
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Biologics announces New Dermatology data to be presented at EADV Congress 2024
Granules India unveils Mobile Cancer Screening Unit at AIG HospitalsGranules India unveils Mobile Cancer Screening Unit at AIG Hospitals
X